2009 was both a challenging and unsettling year for the medtech industry. It has been struggling to manage with the harsh economic conditions, with changing medtech regulations and with the knowledge that further, potentially radical regulatory revisions are ahead. Amanda Maxwell reports ...
Please Login to read the full article.
